Literature DB >> 11041848

Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation.

E J Fernandez1, J Wilken, D A Thompson, S C Peiper, E Lolis.   

Abstract

Herpesvirus-8 macrophage inflammatory protein-II (vMIP-II) binds a uniquely wide spectrum of chemokine receptors. We report the X-ray structure of vMIP-II determined to 2.1 A resolution. Like RANTES, vMIP-II crystallizes as a dimer and displays the conventional chemokine tertiary fold. We have compared the surface topology and electrostatic potential of vMIP-II to those of eotaxin-1, RANTES, and MCP-3, three CCR3 physiological agonists with known three-dimensional structures. Surface epitopes identified on RANTES to be involved in binding to CCR3 are mimicked on the eotaxin-1 and MCP-3 surface. However, the surface topology of vMIP-II in these regions is markedly different. The results presented here indicate that the structural basis for interaction with the chemokine receptor CCR3 by vMIP-II is different from that for the physiological agonists eotaxin-1, RANTES, and MCP-3. These differences on vMIP-II may be a consequence of its broad-range receptor recognition capabilities.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11041848     DOI: 10.1021/bi001166f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

Review 1.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

Review 2.  Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases.

Authors:  Won-Tak Choi; Jing An
Journal:  Exp Biol Med (Maywood)       Date:  2011-05-12

3.  Characterization of structure, dynamics, and detergent interactions of the anti-HIV chemokine variant 5P12-RANTES.

Authors:  Maciej Wiktor; Oliver Hartley; Stephan Grzesiek
Journal:  Biophys J       Date:  2013-12-03       Impact factor: 4.033

4.  Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV).

Authors:  Mindy Miller-Kittrell; Jiqing Sai; Mark Penfold; Ann Richmond; Tim E Sparer
Journal:  Virology       Date:  2007-04-11       Impact factor: 3.616

5.  Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans.

Authors:  Bo Zhao; Patricia J Liwang
Journal:  Biochemistry       Date:  2010-08-24       Impact factor: 3.162

6.  Monomeric solution structure of the prototypical 'C' chemokine lymphotactin.

Authors:  E S Kuloglu; D R McCaslin; M Kitabwalla; C D Pauza; J L Markley; B F Volkman
Journal:  Biochemistry       Date:  2001-10-23       Impact factor: 3.162

7.  Heterologous quaternary structure of CXCL12 and its relationship to the CC chemokine family.

Authors:  James W Murphy; Hua Yuan; Yong Kong; Yong Xiong; Elias J Lolis
Journal:  Proteins       Date:  2010-04

8.  Crystal structure and structural mechanism of a novel anti-human immunodeficiency virus and D-amino acid-containing chemokine.

Authors:  Dongxiang Liu; Navid Madani; Ying Li; Rong Cao; Won-Tak Choi; Sameer P Kawatkar; Mi Youn Lim; Santosh Kumar; Chang-Zhi Dong; Jun Wang; Julie D Russell; Caroline R Lefebure; Jing An; Scott Wilson; Yi-Gui Gao; Luke A Pallansch; Joseph G Sodroski; Ziwei Huang
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

9.  Structural basis of ligand interaction with atypical chemokine receptor 3.

Authors:  Martin Gustavsson; Liwen Wang; Noortje van Gils; Bryan S Stephens; Penglie Zhang; Thomas J Schall; Sichun Yang; Ruben Abagyan; Mark R Chance; Irina Kufareva; Tracy M Handel
Journal:  Nat Commun       Date:  2017-01-18       Impact factor: 14.919

10.  Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibition.

Authors:  Gregg V Crichlow; Hongwen Zhou; Hsin-hao Hsiao; Kendra B Frederick; Maxime Debrosse; Yuande Yang; Ewa J Folta-Stogniew; Hye-Jung Chung; Chengpeng Fan; Enrique M De la Cruz; David Levens; Elias Lolis; Demetrios Braddock
Journal:  EMBO J       Date:  2007-12-06       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.